A Clinical Study in Patients With High-risk Recurrent Primary Hepatocellular Carcinoma Using Autologous TILs
Clinical trial NCT04538313 · UNKNOWN
Trial details
- NCT number
- NCT04538313
- Sponsor
- CAR-T (Shanghai) Cell Biotechnology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-26
- Primary completion
- 2022-10-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.